XOMAP — XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

$25.30-0.32%

Dividend Yield2.12%

Annual Dividend$0.54

Payout Ratio

N/A

Consecutive Years0 yrs

FrequencyN/A

Next Ex-Date

N/A

View full dividend history →

Dividend Grades

vs Healthcare sector

Overall

B-

Yield

N/AGrowth

N/ASafety

Consistency

B-

Performance

Metric	XOMAP	Sector Median	Percentile
Dividend Yield	2.12%	1.77%	57th
Dividend Growth (5Y)	—	5.87%	—
Payout Ratio	—	31.6%	—
Consecutive Years Paid	1	16	5th
1Y Total Return	+0.8%	6.3%	52th

Grades compare this stock to Healthcare sector peers using percentile ranks. A+ = top 10%, F = bottom 10%. See methodology →

1-Year Growth

N/A

3-Year Growth

N/A

5-Year Growth

N/A

10-Year Growth

N/A

Key Dividend Dates

Next Ex-Date

N/A

Next Payment

N/A

Last Ex-Date

Apr 2, 2026

Last Payment

Apr 15, 2026

Dividend History

Ex-Date	Payment Date	Amount	Type	Change
Apr 2, 2026	Apr 15, 2026	$0.5391	Cash	N/A

Payout Ratio (Earnings)

N/A

FCF Payout Ratio

N/A

Peer Comparison

Symbol	Company	Yield	Payout	Years	Growth 5Y	Market Cap
REGN	Regeneron Pharmaceuticals, Inc.	0.51%	8.70%	0	N/A	$76.03B
RPRX	Royalty Pharma plc	1.77%	50.00%	5	24.01%	$21.20B
TECH	Bio-Techne Corporation	0.56%	62.70%	0	0.00%	$8.65B
JBIO	Jade Biosciences, Inc.	9.50%	N/A	0	N/A	$800M
SVA	Sinovac Biotech Ltd.	3400.31%	N/A	0	N/A	$465M

Compare XOMAP:

XOMAP vs REGN XOMAP vs RPRX XOMAP vs TECH XOMAP vs JBIO

About this data

Dividend data sourced from Financial Modeling Prep. Prices updated daily after market close.

Payout ratio — trailing 12-month dividends paid / trailing 12-month net income.

Consecutive years — calendar years with a higher total annual dividend than the prior year.

Growth rates — annualized, comparing the most recent full year total to the total N years prior.

For informational purposes only. Not investment advice.

Data as of May 6, 2026. Source: Financial Modeling Prep. Prices and yields updated daily after market close.